Anti-CD45 and anti-CD52 (Campath) monoclonal antibodies effectively eliminate systemically disseminated human non-Hodgkin's lymphoma B cells in Scid mice

Experimental Hematology

Volumn 24, Issue 8, 1996, Pages 919-926

  De Kroon, J F E M ^a   De Paus, R A ^a   Kluin Nelemans, H C ^a   Kluin, P M ^a   Van Bergen, C A M ^a   Munro, A J ^a   Hale, G ^a   Willemze, R ^a   Frederik Falkenburg, J H ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Anti CD45 mAbs; Anti CD52 mAbs; Immunotherapy; Non Hodgkin's lymphoma; Scid mouse

Indexed keywords

ALEMTUZUMAB; CD45 ANTIGEN; IMMUNOGLOBULIN G2B; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GRAFT; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CANCER SURVIVAL; CHROMOSOME TRANSLOCATION 14; CHROMOSOME TRANSLOCATION 18; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; HISTOPATHOLOGY; MALE; MOUSE; NONHODGKIN LYMPHOMA; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; ANTIGENS, CD; ANTIGENS, CD45; ANTIGENS, NEOPLASM; B-LYMPHOCYTES; CELL LINE; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 18; DNA, NEOPLASM; GLYCOPROTEINS; HUMANS; IMMUNOGLOBULIN G; IMMUNOPHENOTYPING; IMMUNOTHERAPY; LYMPHOCYTE DEPLETION; LYMPHOMA, B-CELL; MALE; MICE; MICE, SCID; RATS; TRANSLOCATION, GENETIC; TUMOR CELLS, CULTURED;

ANIMALIA; MURINAE;

EID: 0030016433     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)